Case number 1:21-cv-01000
Bayer Pharma AG et al v. Taro Pharmaceutical Industries Ltd. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. ยง 652(b). Associated Cases: 1:21-cv-00314-RGA-JLH, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Dec 20, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Notice of Dismissal filed at D.I. 28 has been removed from the docket. This case is consolidated with Lead Civil Action 21-314-RGA. All filings are to be made in the MDL and Lead Civil Action only. (nms) |
| Dec 20, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The Answer filed at D.I. 29 has been removed from the docket. This case is consolidated with Lead Civil Action 21-314-RGA. All filings are to be made in the MDL and Lead Civil Action only. (nms) |
| Dec 15, 2021 | 27 | Order (4) Docket Text: CERTIFIED TRANSFER ORDER - issued by the Panel on the Multi-District Litigation on 12/10/2021. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Member (0) Docket Text: NOTICE: Documents relating to all actions should be filed on the master docket sheet and on the docket sheet of each individual action. Documents relating to two or more, but not all, individual actions should be filed on the master docket sheet, and on the docket sheet of each affected individual action. Documents affecting a single individual action should be filed on the docket sheet of that action and on the master docket sheet. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Dec 15, 2021 | N/A | Remark - MDL Notice to Counsel (0) Docket Text: NOTICE TO COUNSEL: MDL No. 1:21-md-3017 has been opened and assigned to the Honorable Richard G. Andrews. Attorneys of record who will be electronically filing documents and are not registered, should register for E-filing rights through PACER. Please see the docket for further entries. Associated Cases: 1:21-md-03017-RGA et al. (nmg) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: The Rule 16(b) Conference scheduled for 10/28/2021, is CANCELED. Ordered by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | 25 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. The case will be referred to a Magistrate Judge to handle all discovery disputes. The actions are consolidated for all purposes, including trial, and all papers shall be filed in C.A. 21-314 only. Joinder of Parties due by 8/5/2022. Amended Pleadings due by 3/1/2022. Fact Discovery completed by 10/28/2022. Joint Claim Construction Brief due by 8/5/2022. A Markman Hearing is set for 8/23/2022, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/19/2023, at 8:30 AM in Courtroom 6A. A Bench Trial is set to start 5/30/2023 at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Oct 27, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: This matter has been referred to Chief Magistrate Judge Mary Pat Thynge for ADR. Should any party (or all parties) desire to discuss mediation and its timing, the party(ies) shall contact Judge Thynge and her Law Clerk, Daniel Taylor (daniel_taylor@ded.uscourts.gov), to request that a teleconference be scheduled. Ordered by Judge Mary Pat Thynge on 10/27/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 27, 2021 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(Taylor, Daniel) |
| Oct 26, 2021 | 24 | Letter to The Honorable Richard G. Andrews (1) |
| Oct 26, 2021 | 24 | Main Document (15) Docket Text: PROPOSED Scheduling Order, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Attachments: # (1) Letter)(Blumenfeld, Jack) Modified on 10/26/2021 (nms). |
| Oct 20, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] STIPULATION and Proposed Order to Extend Time to respond to Taro's counterclaims to October 28, 2021. Signed by Judge Richard G. Andrews on 10/20/2021. (nms) |
| Oct 19, 2021 | 23 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for plaintiffs to respond to Taro's counterclaims to October 28, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Oct 5, 2021 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims (D.I. 11) to October 21, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Oct 5, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 10/21/2021; Bayer Pharma AG answer due 10/21/2021; Janssen Pharmaceuticals, Inc. answer due 10/21/2021). Signed by Judge Richard G. Andrews on 10/5/2021. (nms) |
| Sep 27, 2021 | 21 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 10/28/2021, at 2:00 PM before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 9/27/2021. (nms) |
| Sep 22, 2021 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims (D.I. 11) to October 7, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Sep 22, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [20] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Taro Pharmaceutical Industries Ltd. answer due 10/7/2021; Taro Pharmaceuticals U.S.A., Inc. answer due 10/7/2021). Signed by Judge Richard G. Andrews on 9/22/2021. (nms) |
| Sep 8, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [19] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 9/23/2021; Bayer Pharma AG answer due 9/23/2021; Janssen Pharmaceuticals, Inc. answer due 9/23/2021). Signed by Judge Richard G. Andrews on 9/8/2021. (nms) |
| Sep 7, 2021 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION and Proposed Order to Extend Time - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 9/7/2021 (nms). |
| Sep 7, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The stipulation filed at D.I. 19 has been removed from the docket. The filing presented was captioned for another matter (18cv976-LPS-CJB). (nms) |
| Aug 30, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 18 in 21-cv-1000-RGA; D.I. 17 in 21-cv-1001-RGA; D.I. 19 in 21-cv-314-RGA; D.I. 14 in 21-cv-732-RGA) MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford, filed by Janssen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 8/30/2021. Associated Cases: 1:21-cv-00314-RGA, 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Aug 27, 2021 | 18 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Thomas D. Rein and Andrew T. Langford - filed by Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Aug 24, 2021 | 17 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to Defendants Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc.'s Answer to Plaintiffs' Complaint for Patent Infringement and Counterclaims (D.I. 11) to September 9, 2021 - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Aug 24, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [17] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: Bayer AG answer due 9/9/2021; Bayer Pharma AG answer due 9/9/2021; Janssen Pharmaceuticals, Inc. answer due 9/9/2021). Signed by Judge Richard G. Andrews on 8/24/2021. (nms) |
| Aug 11, 2021 | 16 | Motion for Leave to Appear Pro Hac Vice (10) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares - filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Aug 11, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (D.I. 16 in 21-cv-1000-RGA; D.I. 12 in 21-cv-732-RGA; D.I. 10 in 21-cv-1001-RGA) MOTION for Pro Hac Vice Appearance of Attorney Bruce R. Genderson, Dov P. Grossman, Alexander S. Zolan, Kathryn S. Kayali, and Julie L. Tavares, filed by Janssen Pharmaceuticals, Inc., Bayer Pharma AG, Bayer AG. Signed by Judge Richard G. Andrews on 8/11/2021. Associated Cases: 1:21-cv-00732-RGA, 1:21-cv-01000-RGA, 1:21-cv-01001-RGA(nms) |
| Aug 6, 2021 | 15 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,415,053 . (Gaza, Anne) |
| Aug 6, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [14] MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson, Esq., and Kimberly A. Beis, Esq., filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. Signed by Judge Richard G. Andrews on 8/6/2021. (nms) |
| Aug 6, 2021 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Kimberly A. Beis and Stephen P. Benson for Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (srs) |
| Aug 5, 2021 | 14 | Motion for Leave to Appear Pro Hac Vice (4) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Stephen P. Benson, Esquire and Kimberly A. Beis, Esquire - filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) |
| Aug 5, 2021 | 13 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: on or about 6/12/2021. Date of Expiration of Patent: January 31, 2039. (Gaza, Anne) |
| Aug 5, 2021 | 12 | Disclosure Statement (3) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alkaloida Chemical Co. ZRT. for Taro Pharmaceutical Industries Ltd.; Other Affiliate Sun Pharmaceutical Industries Ltd., Other Affiliate Taro Pharmaceuticals Industries Ltd. for Taro Pharmaceuticals U.S.A., Inc. filed by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Gaza, Anne) |
| Aug 5, 2021 | 11 | Exhibit 1 (12) |
| Aug 5, 2021 | 11 | Main Document (27) Docket Text: ANSWER to [1] Complaint, and COUNTERCLAIMS against Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc., by Taro Pharmaceutical Industries Ltd., Taro Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit 1)(Gaza, Anne) Modified on 8/6/2021 (nms). |
| Jul 19, 2021 | 10 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Taro Pharmaceuticals U.S.A., Inc. on July 16, 2021, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jul 19, 2021 | 9 | Affidavit of Service (10) Docket Text: AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Taro Pharmaceutical Industries Ltd. on July 16, 2021, filed by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jul 14, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:21-cv-01000-RGA, 1:21-cv-01001-RGA (rjb) |
| Jul 7, 2021 | 1 | Main Document (11) Docket Text: COMPLAINT filed against Taro Pharmaceutical Industries Ltd. and Taro Pharmaceuticals U.S.A., Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3652714.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(srs) |
| Jul 7, 2021 | 8 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Taro Pharmaceutical Industries Ltd. on 7/7/2021. (srs) |
| Jul 7, 2021 | 7 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Taro Pharmaceuticals U.S.A., Inc. on 7/7/2021. (srs) |
| Jul 7, 2021 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (srs) |
| Jul 7, 2021 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Bayer AG, Bayer Pharma AG. (srs) |
| Jul 7, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (srs) |
| Jul 7, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 06/12/2021. Date of Expiration of Patent: 01/31/2039. Thirty Month Stay Deadline: N/A. (srs). |
| Jul 7, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (srs) |
| Jul 7, 2021 | 1 | Civil Cover Sheet (1) |
| Jul 7, 2021 | 1 | Exhibit A (26) |
| Jul 7, 2021 | 1 | Complaint* (1) |
